𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Modulation of cyclin dependent kinase inhibitor proteins and ERK1/2 activity in allylamine-injured vascular smooth muscle cells

✍ Scribed by Sarah A. Jones; Jan L. Patterson; Jun-Tzu Chao; Kenneth S. Ramos; Emily Wilson


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
269 KB
Volume
91
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Chronic oxidative injury by allylamine (AAM) induces proliferative vascular smooth muscle cell (vSMC) phenotypes in the rat aorta similar to those seen in rodent and human atherosclerotic lesions. The proliferative advantage of AAM vSMC compared to control cells is maintained with serial passage of the cells and the advantage is nullified when AAM cells are seeded on a collagen substrate. In this study, we evaluate the potential role of cyclin dependent kinase inhibitors, p27 and p21, and mitogen activated protein (MAP) kinases, ERK1/2, in mediating the proliferative advantage of AAM stressed vSMC over control cells on plastic or collagen substrates. p27 levels in randomly cycling cells were comparable in both cell types irrespective of the substrate. In contrast, basal levels of p21 were 1.9 ± 0.3 (P < 0.05)‐fold higher in randomly cycling AAM cells seeded on plastic compared to controls, a difference that was lost on a collagen substrate. Following G~0~ synchronization, basal levels of both p27 and p21 were higher in AAM cells seeded on plastic compared to controls (1.7 ± 0.2 and 2.0 ± 0.3‐fold, respectively, P < 0.05), but these differences were lost upon mitogenic stimulation. Pyrrolidine dithiocarbamate (PDTC) decreased p27 and p21 levels in cycling AAM cells relative to controls in a substrate‐dependent manner. AAM cells seeded on plastic exhibited enhanced ERK1/2 activation upon mitogenic stimulation; seeding on collagen nullified this advantage. The duration of ERK1/2 activation was prolonged in AAM cells independently of the seeding substrate. We conclude that substrate‐dependent acquisition of proliferative phenotypes following repeated cycles of AAM injury correlates with modulation of the cyclin dependent kinase inhibitors, p27 and p21. © 2004 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Ca2+- and protein kinase C-dependent sti
✍ Surender S. Katoch; Xiaoling Su; Robert S. Moreland 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 2 views

Protein kinase C and mitogen-activated protein (MAP) kinase are expressed in all smooth muscle cells and believed to be important in several physiologically relevant properties of this muscle. Our goal was to determine if protein kinase C and MAP kinase are activated by a simple increase in cellular

Inhibition of PDGF-stimulated and matrix
✍ Kouros Motamed; Sarah E. Funk; Hidenori Koyama; Russell Ross; Elaine W. Raines; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 1 views

## Abstract Interactions among growth factors, cells, and extracellular matrix regulate proliferation during normal development and in pathologies such as atherosclerosis. SPARC (secreted protein, acidic, and rich in cysteine) is a matrix‐associated glycoprotein that modulates the adhesion and prol

Vascular smooth muscle cell-specific reg
✍ Mary M. Kavurma; Levon M. Khachigian 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 323 KB 👁 1 views

## Abstract Smooth muscle cells (SMC) play a central role in common vascular pathologies such as atherosclerosis and restenosis. Understanding the molecular regulation of SMC proliferation at a transcriptional level may provide important clues for the targeted control of vascular hyperplasia. We re

ERK1/2 mediates TNF-α-induced matrix met
✍ Sung-Kwon Moon; Byung-Yoon Cha; Cheorl-Ho Kim 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 386 KB 👁 1 views

## Abstract The expression of matrix metalloproteinase‐9 (MMP‐9) has been implicated in progression of atherosclerotic lesions. The role and importance of the signaling pathway in the transcriptional regulation of MMP‐9 in human aortic smooth muscle cells (HASMC) was examined. Tumor necrosis factor